Results 141 to 150 of about 15,873 (215)

Steryl-Sulfatase [PDF]

, 2020
openaire   +1 more source

Steroid Sulfatase Deficiency: Clinical Manifestations and Psychological Aspects in Light of Current Evidence. [PDF]

Clin Cosmet Investig Dermatol
Fryze M, Pietrzak A.
europepmc   +1 more source

Clinical and Molecular Characterization of Pakistani Mucopolysaccharidosis Families with <i>SGSH</i> and <i>GALNS</i> Deficiencies. [PDF]

Genes (Basel)
Awan FN, Zulfiqar S, Eiman L, Asif M, Hussain MS, Dahl N, Baig SM, Oda H.   +7 more
europepmc   +1 more source

Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model. [PDF]

Front Oncol
Bhattacharyya S, O-Sullivan I, Tobacman JK.   +2 more
europepmc   +1 more source

Mucopolysaccharidosis II with diverse genetic origins in a single family: a case series and literature review. [PDF]

BMC Pediatr
Liu RY, Dai YL, Zou CC.
europepmc   +1 more source

Comprehensive behavioral phenotyping of male Sulf1-deficient mice reveals reduced locomotor activity, altered forelimb gait, and reduced prepulse inhibition. [PDF]

Mol Brain
Keino-Masu K, Chatzigiannis MM, Shoji H, Yamasaki N, Okada T, Horiuchi Y, Arinami T, Hagino Y, Ikeda K, Miyakawa T, Masu M.   +10 more
europepmc   +1 more source

N-acetyl-L-leucine in Neurological Disorders: Mechanisms, Evidence, and Therapeutic Perspectives. [PDF]

Cerebellum
Abid M, Akhtar S, Amjad H, Farooqui SK, Naz T, Shakil S, Alghzawi HM, Hafeez A, Vossenkaul A, Brechbuehl C, Bremova-Ertl T.   +10 more
europepmc   +1 more source

A Cell-Surface-Targeted Fluorogenic Probe for Detection of Sulfatase 2 Activity. [PDF]

Bioconjug Chem
Ding Y, Kowada T, Matsui T, Sasaki N, Mizukami S.   +4 more
europepmc   +1 more source

Draft genome sequence of <i>Flavobacterium</i> sp. ARAG 55.4, an agarolytic bacterium isolated from red algae <i>Gracilaria tenuistipitata</i>. [PDF]

Microbiol Resour Announc
Anh TTV, Chau NB, Thanh VN, Thuy NT.
europepmc   +1 more source

A North Carolina newborn screening pilot for mucopolysaccharidosis II: Evaluating endogenous nonreducing end glycosaminoglycan analysis and IDS sequencing as higher-tier testing options. [PDF]

Genet Med
Kucera KS, Clinard K, Blake SL, Copeland VR, Migliore B, Torrice L, Carter JK, Apoian JN, Tober KA, Thorp E, Gehtland LM, Shone SM, Jalazo ER, Bali D, Young SP, Rehder CW, Raspa M, Muenzer J.   +17 more
europepmc   +1 more source